All poster presentations will be scheduled in one of 5 poster sessions.
Your poster should be mounted by the start of your poster session and removed promptly at the end of your poster session time. We appreciate your cooperation in removing your poster in time and adhering to this schedule.
Participants should be present at their designated poster board(s) during session breaks during their scheduled poster session to answer any questions.
The Organising Committee will not be responsible for posters that are not removed by the end of their assigned poster session.
Please note that the poster programme will be available online only and will not be included in the printed programme book you will receive on-site. Therefore you are requested to familiarize yourself with the poster board number and poster session time assigned to you.
Click here for the detailed poster programme.
|Poster Session and Topic||Board No.|
|September 27 2016 – 07:30-12:15
POSTER SESSION 1
|Psychological Intervention and Miscellaneous Forms of Care||73-76|
|Scleroderma, Myositis and Related Syndromes||77-128|
|Soft Tissue Rheumatism||129-137|
|Spondylarthropathies – Biological and Non-Biological Therapies||138-155|
|Spondylarthropathies – Clinical Aspects and Co-Morbidity||156-197|
|September 27 2016 – 13:45–18:00
POSTER SESSION 2
|Basic Science related to Rheumatic Diseases||1-109|
|Behcet’s Disease and Miscellaneous Rheumatic Conditions||110-128|
|September 28 2016 – 07:30-12:15
POSTER SESSION 3
|Advances in Pain Management||1-3|
|Alternative Medicine (eg. Acupuncture)||4-7|
|Epidemiology, Health Care System and Pharmacoeconomics||8-26|
|Imaging Techniques and Diagnosis||62-101|
|Infection-Related Rheumatic Diseases||102-108|
|Metabolic Bone Diseases and Crystal-Induced Diseases||109-150|
|September 28 2016 – 13:45–18:00
POSTER SESSION 4
|Rehabilitation for Rheumatic Diseases||1-4|
|Rheumatoid Arthritis – Anti-TNFα Therapy||5-30|
|Rheumatoid Arthritis – Clinical Aspects and Co-Morbidity||31-90|
|Rheumatoid Arthritis – Non Biologic Treatment||91-120|
|Rheumatoid Arthritis – Non-TNFα Biological Therapies||121-138|
|Rheumatoid Arthritis – Prognosis, Predictors and Outcome||139-240|
|September 29 2016 – 07:30-13:00
POSTER SESSION 5
|Systemic Lupus Erythematosus, Sjogren’s and Antiphospholipid Syndrome – Clinical Aspects, Comorbidities and Complications||70-194|
|Systemic Lupus Erythematosus, Sjogren’s and Antiphospholipid Syndrome – Therapies||195-235|
Please note the following information for the preparation of your poster:
If you have any further queries regarding your abstract or the Scientific Programme, please contact